Breckpot K - Search Results

1

PD1 signal transduction pathways in T cells.

Arasanz H, Gato-Cañas M, Zuazo M, Ibañez-Vea M, Breckpot K, Kochan G, Escors D. Arasanz H, et al. Among authors: breckpot k. Oncotarget. 2017 Apr 19;8(31):51936-51945. doi: 10.18632/oncotarget.17232. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881701 Free PMC article. Review.

2

Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Breckpot K, Escors D. Breckpot K, et al. Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):328-43. doi: 10.2174/187153009789839156. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19857199 Free PMC article. Review.

3

Lentiviral vectors in gene therapy: their current status and future potential.

Escors D, Breckpot K. Escors D, et al. Among authors: breckpot k. Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):107-19. doi: 10.1007/s00005-010-0063-4. Epub 2010 Feb 9. Arch Immunol Ther Exp (Warsz). 2010. PMID: 20143172 Free PMC article. Review.

4

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

Breckpot K, Escors D, Arce F, Lopes L, Karwacz K, Van Lint S, Keyaerts M, Collins M. Breckpot K, et al. J Virol. 2010 Jun;84(11):5627-36. doi: 10.1128/JVI.00014-10. Epub 2010 Mar 17. J Virol. 2010. PMID: 20237085 Free PMC article.

5

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.

Arce F, Breckpot K, Stephenson H, Karwacz K, Ehrenstein MR, Collins M, Escors D. Arce F, et al. Among authors: breckpot k. Arthritis Rheum. 2011 Jan;63(1):84-95. doi: 10.1002/art.30099. Arthritis Rheum. 2011. PMID: 20967853 Free PMC article.

6

Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.

Arce F, Kochan G, Breckpot K, Stephenson H, Escors D. Arce F, et al. Among authors: breckpot k. Anticancer Agents Med Chem. 2012 Jan;12(1):29-39. doi: 10.2174/187152012798764679. Anticancer Agents Med Chem. 2012. PMID: 21707504 Review.

7

MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

Liechtenstein T, Dufait I, Lanna A, Breckpot K, Escors D. Liechtenstein T, et al. Among authors: breckpot k. Immunol Endocr Metab Agents Med Chem. 2012 Sep;12(3):224-235. doi: 10.2174/187152212802001875. Immunol Endocr Metab Agents Med Chem. 2012. PMID: 22945252 Free PMC article.

8

Targeting lentiviral vectors for cancer immunotherapy.

Arce F, Breckpot K, Collins M, Escors D. Arce F, et al. Among authors: breckpot k. Curr Cancer Ther Rev. 2011 Nov;7(4):248-260. doi: 10.2174/157339411797642605. Curr Cancer Ther Rev. 2011. PMID: 22983382 Free PMC article.

9

PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal.

Liechtenstein T, Dufait I, Bricogne C, Lanna A, Pen J, Breckpot K, Escors D. Liechtenstein T, et al. Among authors: breckpot k. J Clin Cell Immunol. 2012 Oct 30;S12:006. doi: 10.4172/2155-9899.S12-006. J Clin Cell Immunol. 2012. PMID: 23525238 Free PMC article.

10

Retroviral and lentiviral vectors for the induction of immunological tolerance.

Dufait I, Liechtenstein T, Lanna A, Bricogne C, Laranga R, Padella A, Breckpot K, Escors D. Dufait I, et al. Among authors: breckpot k. Scientifica (Cairo). 2012 Dec;2012:694137. doi: 10.6064/2012/694137. Scientifica (Cairo). 2012. PMID: 23526794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters